drugset
drugset / Trial / NCT01963793

Topical Aprepitant in Prurigo Patients

NCT01963793 ↗

Phase 2 Completed 20 enrolled LEO Pharma
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Topical Aprepitant in Prurigo Patients - An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo

Timeline

Start
2013-10
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified 10 unknown Topical

Indications

No indication recorded.